chitosan has been researched along with Atypical Mycobacterial Infection, Disseminated in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arumugam, SK; Doble, M; Mitra, K; Ravindran, R | 1 |
1 other study(ies) available for chitosan and Atypical Mycobacterial Infection, Disseminated
| Article | Year |
|---|---|
Preparation of Curdlan sulphate - Chitosan nanoparticles as a drug carrier to target Mycobacterium smegmatis infected macrophages.
Topics: Animals; beta-Glucans; Cell Survival; Chitosan; Drug Carriers; Drug Delivery Systems; Drug Liberation; Endocytosis; Hydrogen-Ion Concentration; Inflammation; Kinetics; Macrophages; Mice; Mycobacterium Infections, Nontuberculous; Mycobacterium smegmatis; Nanoparticles; Polyelectrolytes; Polymers; RAW 264.7 Cells; Rifampin | 2021 |